Congruence Therapeutics to Participate at the Morgan Stanley 21st Annual Global Healthcare Conference By Araceli Richardson|2023-09-06T05:04:09-07:0009.06.2023|News|0 Comments Read More
Congruence Therapeutics Announces Presentations at the 2023 European and North America CCG UGM & Conferences By Araceli Richardson|2023-05-25T05:05:14-07:0005.25.2023|News|0 Comments Read More
Congruence Therapeutics to Present at Multiple Investor Conferences in May By Araceli Richardson|2023-05-04T13:58:39-07:0005.04.2023|News|0 Comments Read More
Congruence Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference By Araceli Richardson|2023-05-04T13:59:16-07:0004.12.2023|News|0 Comments Read More
Congruence Therapeutics Announces Close of Series A Extension, Bringing Total Round to Over US$65 Million By Araceli Richardson|2023-03-06T05:02:41-08:0003.06.2023|News|0 Comments Read More
Congruence Therapeutics to Present at the January 2023 Biotech Showcase in San Francisco By Araceli Richardson|2023-01-29T08:43:59-08:0012.07.2022|News|0 Comments Read More
Congruence Therapeutics Strengthens Leadership Team with Appointment of Dr. Sharath Hegde as Chief Scientific Officer By Araceli Richardson|2023-01-29T09:04:19-08:0011.22.2022|News|0 Comments Read More
AI-driven Congruence Therapeutics gets $50M to stabilize misfolded proteins By congruence1|2023-01-29T08:53:54-08:0002.09.2022|News|0 Comments Read More
Congruence Therapeutics announces series A financing By congruence1|2023-01-29T08:55:46-08:0002.08.2022|News|0 Comments Read More
Congruence Raises $50 million to Target Rare Diseases of Protein Misfolding By congruence1|2023-01-29T08:57:54-08:0002.08.2022|News|0 Comments Read More
